<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36220871</PMID><DateCompleted><Year>2022</Year><Month>10</Month><Day>13</Day></DateCompleted><DateRevised><Year>2022</Year><Month>12</Month><Day>28</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2045-2322</ISSN><JournalIssue CitedMedium="Internet"><Volume>12</Volume><Issue>1</Issue><PubDate><Year>2022</Year><Month>Oct</Month><Day>11</Day></PubDate></JournalIssue><Title>Scientific reports</Title><ISOAbbreviation>Sci Rep</ISOAbbreviation></Journal><ArticleTitle>A novel assessment of fine-motor function reveals early hindlimb and detectable forelimb deficits in an experimental model of ALS.</ArticleTitle><Pagination><StartPage>17010</StartPage><MedlinePgn>17010</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">17010</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41598-022-20333-1</ELocationID><Abstract><AbstractText>Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disorder associated with the loss of cortical and spinal motor neurons (MNs) and muscle degeneration (Kiernan et al. in Lancet 377:942-955, 2011). In the preclinical setting, functional tests that can detect early changes in motor function in rodent models of ALS are critical to understanding the etiology of the disease and treatment development. Here, we established a string-pulling paradigm that can detect forelimb and hindlimb motor deficits in the SOD1 mouse model of ALS earlier than traditional motor performance tasks. Additionally, our findings indicate that early loss of forelimb and hindlimb function is correlated with cortical and spinal MN loss, respectively. This task is not only ecological, low-cost, efficient, and non-onerous, it also requires little animal handling and reduces the stress placed on the animal. It has long been a concern in the field that the SOD1 mouse does not display forelimb motor deficits and does not give researchers a complete picture of the disease. Here, we provide evidence that the SOD1 model does in fact develop early forelimb motor deficits due to the task's ability to assess fine-motor function, reconciling this model with the various clinical presentation of ALS. Taken together, the string-pulling paradigm may provide novel insights into the pathogenesis of ALS, offer nuanced evaluation of prospective treatments, and has high translational potential to the clinic.</AbstractText><CopyrightInformation>&#xa9; 2022. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Khademullah</LastName><ForeName>C Sahara</ForeName><Initials>CS</Initials><AffiliationInfo><Affiliation>CERVO Brain Research Centre, Universit&#xe9; Laval, 2601 Chemin de la Canardi&#xe8;re, Quebec, QC, G1J 2G3, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>De Koninck</LastName><ForeName>Yves</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>CERVO Brain Research Centre, Universit&#xe9; Laval, 2601 Chemin de la Canardi&#xe8;re, Quebec, QC, G1J 2G3, Canada. yves.dekoninck@neuro.ulaval.ca.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>10</Month><Day>11</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Sci Rep</MedlineTA><NlmUniqueID>101563288</NlmUniqueID><ISSNLinking>2045-2322</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>EC 1.15.1.1</RegistryNumber><NameOfSubstance UI="D013482">Superoxide Dismutase</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.15.1.1</RegistryNumber><NameOfSubstance UI="D000072105">Superoxide Dismutase-1</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004195" MajorTopicYN="N">Disease Models, Animal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005552" MajorTopicYN="N">Forelimb</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006614" MajorTopicYN="N">Hindlimb</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008822" MajorTopicYN="N">Mice, Transgenic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013482" MajorTopicYN="N">Superoxide Dismutase</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000072105" MajorTopicYN="N">Superoxide Dismutase-1</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>1</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>9</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>10</Month><Day>11</Day><Hour>23</Hour><Minute>23</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>10</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>10</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36220871</ArticleId><ArticleId IdType="pmc">PMC9553953</ArticleId><ArticleId IdType="doi">10.1038/s41598-022-20333-1</ArticleId><ArticleId IdType="pii">10.1038/s41598-022-20333-1</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Kiernan MC, et al. Amyotrophic lateral sclerosis. Lancet. 2011;377:942&#x2013;955. doi: 10.1016/S0140-6736(10)61156-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(10)61156-7</ArticleId><ArticleId IdType="pubmed">21296405</ArticleId></ArticleIdList></Reference><Reference><Citation>Renton AE, Chi&#xf2; A, Traynor BJ. State of play in amyotrophic lateral sclerosis genetics. Nat. Neurosci. 2013;17:17&#x2013;23. doi: 10.1038/nn.3584.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.3584</ArticleId><ArticleId IdType="pmc">PMC4544832</ArticleId><ArticleId IdType="pubmed">24369373</ArticleId></ArticleIdList></Reference><Reference><Citation>Karch CM, Prudencio M, Winkler DD, Hart PJ, Borchelt DR. Role of mutant SOD1 disulfide oxidation and aggregation in the pathogenesis of familial ALS. Proc. Natl. Acad. Sci. U.S.A. 2009;106:7774&#x2013;7779. doi: 10.1073/pnas.0902505106.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0902505106</ArticleId><ArticleId IdType="pmc">PMC2675570</ArticleId><ArticleId IdType="pubmed">19416874</ArticleId></ArticleIdList></Reference><Reference><Citation>Shibata N. Transgenic mouse model for familial amyotrophic lateral sclerosis with superoxide dismutase-1 mutation. Neuropathology. 2001;21:82&#x2013;92.</Citation><ArticleIdList><ArticleId IdType="pubmed">11304046</ArticleId></ArticleIdList></Reference><Reference><Citation>Ozdinler PH, et al. Corticospinal motor neurons and related subcerebral projection neurons undergo early and specific neurodegeneration in hSOD1G93A transgenic ALS mice. J. Neurosci. 2011;31:4166&#x2013;4177. doi: 10.1523/JNEUROSCI.4184-10.2011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.4184-10.2011</ArticleId><ArticleId IdType="pmc">PMC3643523</ArticleId><ArticleId IdType="pubmed">21411657</ArticleId></ArticleIdList></Reference><Reference><Citation>Clark RM, Brizuela M, Blizzard CA, Dickson TC. Reduced excitability and increased neurite complexity of cortical interneurons in a familial mouse model of amyotrophic lateral sclerosis. Front. Cell. Neurosci. 2018;12:328. doi: 10.3389/fncel.2018.00328.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2018.00328</ArticleId><ArticleId IdType="pmc">PMC6172321</ArticleId><ArticleId IdType="pubmed">30323744</ArticleId></ArticleIdList></Reference><Reference><Citation>Khademullah CS, et al. Cortical interneuron-mediated inhibition delays the onset of amyotrophic lateral sclerosis. Brain. 2020;143:800&#x2013;810. doi: 10.1093/brain/awaa034.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awaa034</ArticleId><ArticleId IdType="pubmed">32203578</ArticleId></ArticleIdList></Reference><Reference><Citation>Marques C, Burg T, Scekic-Zahirovic J, Fischer M, Rouaux C. Upper and lower motor neuron degenerations are somatotopically related and temporally ordered in the sod1 mouse model of amyotrophic lateral sclerosis. Brain Sci. 2021;11:369. doi: 10.3390/brainsci11030369.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/brainsci11030369</ArticleId><ArticleId IdType="pmc">PMC7998935</ArticleId><ArticleId IdType="pubmed">33805792</ArticleId></ArticleIdList></Reference><Reference><Citation>Oliv&#xe1;n S, et al. Comparative study of behavioural tests in the SOD1G93A mouse model of amyotrophic lateral sclerosis. Exp. Anim. 2015;64:147&#x2013;153. doi: 10.1538/expanim.14-0077.</Citation><ArticleIdList><ArticleId IdType="doi">10.1538/expanim.14-0077</ArticleId><ArticleId IdType="pmc">PMC4427729</ArticleId><ArticleId IdType="pubmed">25736480</ArticleId></ArticleIdList></Reference><Reference><Citation>Knippenberg S, Thau N, Dengler R, Petri S. Significance of behavioural tests in a transgenic mouse model of amyotrophic lateral sclerosis (ALS) Behav. Brain Res. 2010;213:82&#x2013;87. doi: 10.1016/j.bbr.2010.04.042.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbr.2010.04.042</ArticleId><ArticleId IdType="pubmed">20450936</ArticleId></ArticleIdList></Reference><Reference><Citation>Brooks SP, Dunnett SB. Tests to assess motor phenotype in mice: A user&#x2019;s guide. Nat. Rev. Neurosci. 2009;10:519&#x2013;529. doi: 10.1038/nrn2652.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrn2652</ArticleId><ArticleId IdType="pubmed">19513088</ArticleId></ArticleIdList></Reference><Reference><Citation>Mancuso R, et al. Resveratrol improves motoneuron function and extends survival in SOD1G93A ALS mice. Neurotherapeutics. 2014;11:419.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3996124</ArticleId><ArticleId IdType="pubmed">24414863</ArticleId></ArticleIdList></Reference><Reference><Citation>Hayworth CR, Gonzalez-Lima F. Pre-symptomatic detection of chronic motor deficits and genotype prediction in congenic B6.SOD1G93A ALS mouse model. Neuroscience. 2009;164:975&#x2013;985. doi: 10.1016/j.neuroscience.2009.08.031.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroscience.2009.08.031</ArticleId><ArticleId IdType="pmc">PMC2783710</ArticleId><ArticleId IdType="pubmed">19699279</ArticleId></ArticleIdList></Reference><Reference><Citation>Smittkamp SE, Brown JW, Stanford JA. Time-course and characterization of orolingual motor deficits in B6SJL-Tg(SOD1-G93A)1Gur/J mice. Neuroscience. 2008;151:613&#x2013;621. doi: 10.1016/j.neuroscience.2007.10.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroscience.2007.10.017</ArticleId><ArticleId IdType="pmc">PMC2244802</ArticleId><ArticleId IdType="pubmed">18061359</ArticleId></ArticleIdList></Reference><Reference><Citation>Miana-Mena FJ, et al. Optimal methods to characterize the G93A mouse model of ALS. Amyotroph. Lateral Scler. Neuron Disord. 2005;6:55&#x2013;62. doi: 10.1080/14660820510026162.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/14660820510026162</ArticleId><ArticleId IdType="pubmed">16036427</ArticleId></ArticleIdList></Reference><Reference><Citation>Weydt P, Hong SY, Kliot M, M&#xf6;ller T. Assessing disease onset and progression in the SOD1 mouse model of ALS. NeuroReport. 2003;14:1051&#x2013;1054.</Citation><ArticleIdList><ArticleId IdType="pubmed">12802201</ArticleId></ArticleIdList></Reference><Reference><Citation>Mandillo S, et al. Reliability, robustness, and reproducibility in mouse behavioral phenotyping: A cross-laboratory study. Physiol. Genom. 2008;34:243. doi: 10.1152/physiolgenomics.90207.2008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/physiolgenomics.90207.2008</ArticleId><ArticleId IdType="pmc">PMC2519962</ArticleId><ArticleId IdType="pubmed">18505770</ArticleId></ArticleIdList></Reference><Reference><Citation>Mead RJ, et al. Optimised and rapid pre-clinical screening in the SOD1G93A transgenic mouse model of amyotrophic lateral sclerosis (ALS) PLoS&#xa0;One. 2011;6:e23244. doi: 10.1371/journal.pone.0023244.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0023244</ArticleId><ArticleId IdType="pmc">PMC3158065</ArticleId><ArticleId IdType="pubmed">21876739</ArticleId></ArticleIdList></Reference><Reference><Citation>Lewis KE, et al. Microglia and motor neurons during disease progression in the SOD1G93A mouse model of amyotrophic lateral sclerosis: Changes in arginase1 and inducible nitric oxide synthase. J. Neuroinflamm. 2014;11:1&#x2013;18. doi: 10.1186/1742-2094-11-55.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1742-2094-11-55</ArticleId><ArticleId IdType="pmc">PMC3994340</ArticleId><ArticleId IdType="pubmed">24655927</ArticleId></ArticleIdList></Reference><Reference><Citation>Haulcomb MM, et al. Locomotor analysis identifies early compensatory changes during disease progression and subgroup classification in a mouse model of amyotrophic lateral sclerosis. Neural Regen. Res. 2017;12:1664. doi: 10.4103/1673-5374.217346.</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/1673-5374.217346</ArticleId><ArticleId IdType="pmc">PMC5696848</ArticleId><ArticleId IdType="pubmed">29171432</ArticleId></ArticleIdList></Reference><Reference><Citation>Alves CJ, et al. Early motor and electrophysiological changes in transgenic mouse model of amyotrophic lateral sclerosis and gender differences on clinical outcome. Brain Res. 2011;1394:90&#x2013;104. doi: 10.1016/j.brainres.2011.02.060.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainres.2011.02.060</ArticleId><ArticleId IdType="pubmed">21354109</ArticleId></ArticleIdList></Reference><Reference><Citation>Est&#xe9;vez-Silva HM, et al. Pridopidine modifies disease phenotype in a SOD1 mouse model of amyotrophic lateral sclerosis. Eur. J. Neurosci. 2022;55:1356&#x2013;1372. doi: 10.1111/ejn.15608.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ejn.15608</ArticleId><ArticleId IdType="pmc">PMC9305776</ArticleId><ArticleId IdType="pubmed">35080077</ArticleId></ArticleIdList></Reference><Reference><Citation>Vinsant S, et al. Characterization of early pathogenesis in the SOD1G93A mouse model of ALS: Part II, results and discussion. Brain Behav. 2013;3:431&#x2013;457. doi: 10.1002/brb3.142.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/brb3.142</ArticleId><ArticleId IdType="pmc">PMC3869683</ArticleId><ArticleId IdType="pubmed">24381813</ArticleId></ArticleIdList></Reference><Reference><Citation>Niessen H, et al. In vivo quantification of spinal and bulbar motor neuron degeneration in the G93A-SOD1 transgenic mouse model of ALS by T2 relaxation time and apparent diffusion coefficient. Exp. Neurol. 2006;201:293&#x2013;300. doi: 10.1016/j.expneurol.2006.04.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.expneurol.2006.04.007</ArticleId><ArticleId IdType="pubmed">16740261</ArticleId></ArticleIdList></Reference><Reference><Citation>Hegedus J, Putman C, Gordon T. Time course of preferential motor unit loss in the SOD1 G93A mouse model of amyotrophic lateral sclerosis. Neurobiol. Dis. 2007;28:154&#x2013;164. doi: 10.1016/j.nbd.2007.07.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2007.07.003</ArticleId><ArticleId IdType="pubmed">17766128</ArticleId></ArticleIdList></Reference><Reference><Citation>Clark RM, Blizzard CA, Young KM, King AE, Dickson TC. Calretinin and neuropeptide Y interneurons are differentially altered in the motor cortex of the SOD1G93A mouse model of ALS. Sci. Rep. 2017;7:44461. doi: 10.1038/srep44461.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep44461</ArticleId><ArticleId IdType="pmc">PMC5353592</ArticleId><ArticleId IdType="pubmed">28294153</ArticleId></ArticleIdList></Reference><Reference><Citation>Boill&#xe9;e S, Vande Velde C, Cleveland DW. ALS: A disease of motor neurons and their nonneuronal neighbors. Neuron. 2006;52:39&#x2013;59. doi: 10.1016/j.neuron.2006.09.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2006.09.018</ArticleId><ArticleId IdType="pubmed">17015226</ArticleId></ArticleIdList></Reference><Reference><Citation>Philips T, Rothstein JD. Glial cells in amyotrophic lateral sclerosis. Exp. Neurol. 2014;262(Pt B):111&#x2013;120. doi: 10.1016/j.expneurol.2014.05.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.expneurol.2014.05.015</ArticleId><ArticleId IdType="pmc">PMC4241182</ArticleId><ArticleId IdType="pubmed">24859452</ArticleId></ArticleIdList></Reference><Reference><Citation>Morandell K, Huber D. The role of forelimb motor cortex areas in goal directed action in mice. Sci. Rep. 2017;7:1&#x2013;14. doi: 10.1038/s41598-017-15835-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-017-15835-2</ArticleId><ArticleId IdType="pmc">PMC5693936</ArticleId><ArticleId IdType="pubmed">29150620</ArticleId></ArticleIdList></Reference><Reference><Citation>Jeong M, et al. Interhemispheric cortico-cortical pathway for sequential bimanual movements in mice. eNeuro. 2021 doi: 10.1523/ENEURO.0200-21.2021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/ENEURO.0200-21.2021</ArticleId><ArticleId IdType="pmc">PMC8387156</ArticleId><ArticleId IdType="pubmed">34348983</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown AR, Mitra S, Teskey GC, Boychuk JA. Complex forelimb movements and cortical topography evoked by intracortical microstimulation in male and female mice. Cereb. Cortex. 2022 doi: 10.1093/CERCOR/BHAC178.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/CERCOR/BHAC178</ArticleId><ArticleId IdType="pubmed">35511684</ArticleId></ArticleIdList></Reference><Reference><Citation>Dutta K, Thammisetty SS, Boutej H, Bareil C, Julien J-P. Mitigation of ALS pathology by neuron-specific inhibition of nuclear factor kappa B signaling. J. Neurosci. 2020;40:5137&#x2013;5154. doi: 10.1523/JNEUROSCI.0536-20.2020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.0536-20.2020</ArticleId><ArticleId IdType="pmc">PMC7314413</ArticleId><ArticleId IdType="pubmed">32457070</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>